199 related articles for article (PubMed ID: 7164036)
1. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
2. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
Fouque F; Joseph D; Vargaftig BB
Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
[TBL] [Abstract][Full Text] [Related]
4. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
Fouque F; Vargaftig BB
Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
[TBL] [Abstract][Full Text] [Related]
5. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
6. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
Lauri D; Cerletti C; de Gaetano G
Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
[TBL] [Abstract][Full Text] [Related]
7. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
Altman R; Scazziota A; Rouvier J; Cacchione R
Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
[TBL] [Abstract][Full Text] [Related]
8. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
10. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
11. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
12. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
Fouque F; Vargaftig BB
J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation.
Rao GH; White JG
Prostaglandins Leukot Med; 1982 Oct; 9(4):459-72. PubMed ID: 6817343
[TBL] [Abstract][Full Text] [Related]
14. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Altman R; Scazziota A
Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
[TBL] [Abstract][Full Text] [Related]
15. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
Steen VM; Holmsen H; Aarbakke G
Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
[TBL] [Abstract][Full Text] [Related]
16. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
Honey AC; Lad N; Tuffin DP
Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
[TBL] [Abstract][Full Text] [Related]
19. Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
Juhan-Vague I; Chignard M; Poisson C; Roul C; Billerey M; Buonocore M; Driss F; Vague P; Benveniste J
Thromb Res; 1985 Apr; 38(1):83-9. PubMed ID: 3923649
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]